Symbol Name ID |
Slc9b2
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 MGI:2140077 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Slc9b2Gt(D174F03)Wrst/Slc9b2Gt(D174F03)Wrst involves: 129S2/SvPas * C57BL/6 |
decreased insulin secretion | J:197386 |
increased circulating glucose level | J:197386 | |
normal skeleton phenotype | J:162142 | |
Slc9b2tm1.1(KOMP)Vlcg/Slc9b2tm1.1(KOMP)Vlcg C57BL/6N-Slc9b2tm1.1(KOMP)Vlcg/Ucd |
increased circulating phosphate level | J:211773 |
Slc9b2tm1.1Dgfu/Slc9b2+ involves: 129 * C57BL/6 |
increased circulating glucose level | J:197386 |
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu B6.129-Slc9b2tm1.1Dgfu |
decreased insulin secretion | J:197386 |
increased circulating glucose level | J:197386 | |
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu involves: 129 * C57BL/6 |
decreased circulating insulin level | J:197386 |
decreased insulin secretion | J:197386 | |
increased circulating glucose level | J:197386 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|